5.2K
Downloads
52
Episodes
The Life Sciences D’n’A podcast is hosted by AI and data analytics experts and pharma industry veterans Nagaraja Srivatsan and Amar Drawid. They explore the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Episodes
Mar 28, 2024
Mar 28, 2024
51 min
Nagaraja Srivatsan, founder of the consulting firm Vidya Seva, sits down with Amar Drawid to discuss the application of data analytics and AI to healthcare and the life sciences, how it has evolved, and why it will be a competitive differentiator for companies that successfully capitalize the potential of these technologies.
Mar 14, 2024
Mar 14, 2024
49 min
Jen Nwankwo, CEO of 1910 Genetics, sits down with Amar Drawid to discuss her company’s approach to AI drug discovery, how it is seeking to address big challenges that plague the industry, and why the company is agnostic to drug modality.
Feb 22, 2024
Feb 22, 2024
42 min
In this episode Tuvik Beker, CEO of Pangea Biomed, sits down with Dr. Amar Drawid to discuss the evolution of precision medicine, the challenges in matching the right drugs to the right patient, and how Pangea uses AI to analyze expression data and gene interaction maps to select the most effective drugs for individual patients.
Jan 30, 2024
Jan 30, 2024
40 min
Data analytics has evolved significantly in the pharmaceutical industry, providing sales professionals with better insights and decision-making capabilities. On this episode, Dr. Amar Drawid sits down with 40-year biopharmaceutical industry veteran Jonathan Blutfield, principal consultant with TriRadial Solutions, to discuss the evolution of data analytics for commercial teams, how sales reps play a vital role in personalizing interactions with healthcare professionals, and how companies can enhance the effectiveness of data analytics tools and integrate them into their sales strategies.
Nagaraja Srivatsan
Srivatsan, host of the Life Sciences D'n'A podcast, has more than 30 years of experience in growing businesses in the Digital, Data, AI, Analytics, IT, Product and Operations management areas across several industry verticals. Currently, Srivatsan serves as the CEO of Endpoint Clinical, a global leader in Randomization and Trial Supply Management (RTSM). He is spearheading the next phase of growth, strengthening Endpoint’s position as a trusted partner in accelerating clinical trials and bringing innovative treatments to patients. Additionally, he advises companies, helping them unlock exponential growth opportunities.